Michael Quirmbach

16.07.2024 • News

CordenPharma Invests €900 Million in Peptide Platform Expansion

CordenPharma announced its largest strategic investment to date, committing to spend ~€900m over the next three years to enhance its peptide technology platform.

16.10.2020 • Topics • Strategy

Expert Interview: Michael Quirmbach, CordenPharma

So far, the pharmaceutical industry — including CMOs/CDMOs and CROs — has responded well to the outbreak of the Covid-19 pandemic. However, the coronavirus crisis has uncovered problems that have been smoldering beneath the surface and need to be addressed. That supply chains are vulnerable to disruption when major development, production and transportation hubs are blocked or shut down has become painfully obvious.

05.09.2019 • Topics • Strategy

Experts Statements: Michael Quirmbach, CordenPharma

26.07.2019 • News

Michael Quirmbach Appointed as CEO and President of CordenPharma

12.12.2016 • Topics • Innovation

Experts Statements: Dr. Michael Quirmbach, Corden-Pharma International

06.12.2016 • Topics • Innovation

The Winning Formula

26.09.2016 • Whitepaper

Trends in Chemical & Pharmaceutical Research

08.09.2016 • Topics • Strategy

The Winning Formula

Top-Feature

Evonik Industries AG

Maximize the Potential of Spent Hydroprocessing Catalysts

Ecocool GmbH

Transport Logistic: Ecocool Presents Packaging Solutions for Pharmaceutical Transports

IMCD Deutschland GmbH

Fostering Innovation and Collaboration

CHEManager Spotlight

Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Corden Pharma International